Comparative evaluation of the local application of dimethyl sulfoxide in an experimental spinal cord injury model

Aim: To investigate the efficacy of the local application of dimethyl sulfoxide (DMSO) in an experimental spinal cord injury model.Material and Methods: This study included 20 Sprague–Dawley rats (12 males and 8 females) that were aged 4–6 months andweighed 160–300 g. The control and experimental groups had equal number of rats (n = 10). Ketamine hydrochloride (50 mg/kg)and diazepam (2 mg/kg) in saline solution were intraperitoneally administered. A rod bearing, glass tube through which the weightwas passed, and modified Allen trauma device were used to induce trauma. The rats then developed post-traumatic flask paraplegia.DMSO was topically applied to the epidural space after a two-level laminectomy. The global motor performance of the rats wasevaluated.Results: The motor performance of the experimental and control groups was assessed after trauma. Results showed that the ratspresented with significantly decreased motor performance. In particular, the performance of the experimental group improved overtime, and recovery accelerated after the fifth day. Based on a histological examination of the lesion sites after the tenth day, theexperimental and control groups significantly differed in terms of global motor performance.Conclusion: The efficacy of the agent was evaluated via global motor performance assessment and histological examination. In theexperimental group, a statistically significant difference was observed in terms of global motor performance, which was assessedusing the tilted floor method, on the fifth day after trauma. Histologically, no statistically significant difference was noted betweenthe two groups.

PDF

___

1. Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976) 2001;15;26.
2. Hosseini SM, Sharafkhah A, Ziaee SM. Spinal cord derived neural precursor cells as a preventive therapy for spinal cord injury. Asian J Neurosurg 2018;13:1101-07.
3. National Spinal Cord Injury Statistical Center. Spinal Cord Injury Facts and Figures at a Glance. J Spinal Cord Med 2010;33:439-40.
4. Tator CH. Epidemiology and general characteristics of the spinal cord injured patient. In Tator CH, Benzel EC (eds): Contemporary Management of Spinal Cord Injury; From Impact to Rehabilitation. Park Ridge, IL: American Association of Neurological Surgeons Publications Committee, 2000, pp 15-19.
5. Wyndaele M, Wyndaele JJ. Incidence, prevalence and epidemiology of spinal cord injury: What learns a worldwide literature survey? Spinal Cord 2006;44:523- 9.
6. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 2000;93:1-7.
7. Hurlbert RJ, Hadley MN, Walters BC, et al. Pharmacological therapy for acute spinal cord injury. Neurosurgery 2015;76:71-83.
8. Tanaka C, Tagami T, Kaneko J, et al. Early versus late surgery after cervical spinal cord injury: A Japanese nationwide trauma database study. J Orthop Surg Res 2019;14:302.
9. Gelb DE, Hadley MN, Aarabi B, et al. Initial closed reduction of cervical spinal fracture-dislocation injuries. Neurosurgery 2013;72:73-83.
10. Figley SA, Austin JW, Rowland JW, et al. Pathophysiology of spinal cord injury. The Cervical Spine. 5th ed. United States: Lippincott, Williams and Wilkins; 2011.
11. Jacob SW, de la Torre JC. Pharmacology of dimethyl sulfoxide in cardiac and CNS damage. Pharmacol Rep 2009;61:225-35.
12. Bardutzky J, Meng X, Bouley J, et al. Effects of intravenous dimethyl sulfoxide on ischemia evolution in a rat permanent occlusion model. J Cereb Blood Flow Metab 2005;25:968-77.
13. Goldsmith HS. Can the standard treatment of acute spinal cord injury be improved? Perhaps the time has come. Neurol Res 2007;29:16-20.
14. de la Torre JC. Synergic activity of combined prostacyclin: dimethyl sulfoxide in experimental brain ischemia. Can J Physiol Pharmacol 1991;69:191-8.
15. Kajihara K, Kawanaga H, de la Torre JC, et al. DMSO in the treatment of experimental acute spinal cord injury. Surg Neurol 1973;1:16-22.
16. Goodnough J, Allen N, Nesham ME, et al. The effect of dimethyl sulfoxide on gray matter injury in experimental spinal cord trauma. Surg Neurol 1980;13:273-6.
17. Zileli M, Ovul I, Dalbasti T. Effects of methyl prednisolone, dimethyl sulphoxide and naloxone in experimental spinal cord injuries in rats. Neurol Res 1988;10:232-5.
18. Yilmaz C, Ozger O, Kabatas S, et al. The preventive effect of mexiletine on cerebral ischemic injury following experimental middle cerebral artery occlusion. Turk Neurosurg 2009;19:367-73.
19. de la Torre JC, Kawanaga HM, Johnson CM, et al. Dimethyl sulfoxide in central nervous system trauma. Ann N Y Acad Sci 1975;243:362-89.
20. Kulah A, Akar M, Baykut L. Dimethyl sulfoxide in the management of patients with brain swelling and increased intracranial pressure after severe closed head injury. Neurochirurgia (Stuttg) 1990;33:177-80.
21. Mueller LP, Theurich S, Christopeit M, et al. Neurotoxicity upon infusion of dimethylsulfoxidecryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease Neurochirurgia (Stuttg) 1990;33:177-80.
22. Lu C, Mattson MP. Dimethyl sulfoxide suppresses NMDA- and AMPA-induced ion currents and calcium influx and protects against excitotoxic death in hippocampal neurons. Exp Neurol 2001;170:180-5.
23. Markov AK, Fletcher JA, Finch C. Prevention of oxygen radicals-induced myocardial reperfusion injury with fructose 1,6-diphosphate (FDP). Clin Res 1986;34:208A.
24. de la Torre JC, Johnson CM, Goode DJ, et al. Pharmacologic treatment and evaluation of permanent experimental spinal cord trauma. Neurology 1975;25:508-14.